News

India`s SII could resume Covishield shot production as COVID cases rise The Serum Institute of India (SII) could resume production of the Covishield COVID-19 vaccine, a company spokesperson said on Wednesday, as infections rise in the country. The world's biggest vaccine maker already has a stock of 6 million doses of Covovax, a version of a Novavax vaccine, the spokesperson added. Covishield is a version of an AstraZeneca shot.
India`s SII could resume Covishield shot production as COVID cases rise
India`s SII could resume Covishield shot production as COVID cases rise
Source: Reuters
12/04/2023 5:11:50 PM
Key Stock Ideas: AstraZeneca, GAIL, DLF, Minda Corporation - ARETE Securities Key News AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer: Drug firm AstraZeneca India on Friday said it has received approval from the domestic drug regulator to market a drug to treat biliary tract cancer (BTC) in the country. The company has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Durvalumab, the drug firm said in a statement. BTC is a group of rare and aggressive gastrointestinal (GI) cancers that form in the cells of the b...
Key Stock Ideas: AstraZeneca, GAIL, DLF, Minda Corporation - ARETE Securities
Key Stock Ideas: AstraZeneca, GAIL, DLF, Minda Corporation - ARETE Securities
Source: ARETE Securities Ltd
20/02/2023 9:27:44 AM
Key Stock News: AstraZeneca, Flipkart , SBI , Adani Group, Singapore Airlines - ARETE Securities AstraZeneca India gets regulator's approval to market anti-diabetes drug Drug firm AstraZeneca India on Tuesday said it has received approval from the country's drug regulator to market anti-diabetes medication Dapagliflozin. The company said it has received approval from the Central Drugs Standard Control Organization (CDCSCO) for the drug indicated for diabetes patients with chronic kidney disease (CKD). Flipkart to go for $700 million ESOP buyback during PhonePe funding: ...
Key Stock News: AstraZeneca, Flipkart , SBI , Adani Group, Singapore Airlines - ARETE Securities
Key Stock News: AstraZeneca, Flipkart , SBI , Adani Group, Singapore Airlines - ARETE Securities
Source: ARETE Securities Ltd
30/11/2022 9:50:03 AM
Samsung Biologics to manufacture AstraZeneca's Covid antibody therapy British-Swedish pharmaceutical giant AstraZeneca on Tuesday said that Samsung Biologics, the biotech arm of Samsung Group, will manufacture its antibody combination against Covid-19. Under an agreement valued at approximately $380 million, Samsung Biologics will manufacture Evusheld -- AstraZeneca's combination of two long-acting antibodies in development for the potential treatment of Covid-19 -- at its plant in Songdo, Incheon, 40 km west of Seoul, Yonhap news agency reported. The...
Samsung Biologics to manufacture AstraZeneca's Covid antibody therapy
Samsung Biologics to manufacture AstraZeneca's Covid antibody therapy
Source: IANS
14/12/2021 3:00:38 PM
Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI NEW DELHI  - Global vaccine-sharing network COVAX is still seeing strong demand for India-made doses of the AstraZeneca COVID-19 shot, its co-lead GAVI said, following comments from producer the Serum Institute of India (SII) that uptake had slowed sharply. The SII, the world's biggest vaccine maker, told India's CNBC-TV18 this week it would temporarily halve the vaccine's production as it had no fresh orders from the Indian government and COVAX was taking fewer doses than...
Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI
Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI
Source: Reuters
9/12/2021 1:40:21 PM
India`s Serum Institute plans to start vaccine production outside India - The Times The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times. "There's going to be an announcement in the next few days," Adar Poonawalla was quoted as saying by the newspaper in an interview published on Friday. Poonawalla said last week that the Serum Institute would be able to raise its monthly output to ...
India`s Serum Institute plans to start vaccine production outside India - The Times
India`s Serum Institute plans to start vaccine production outside India - The Times
Source: Reuters
2/05/2021 8:40:21 AM
India's Serum Institute plans to start vaccine production outside India - The Times The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times. "There's going to be an announcement in the next few days," Adar Poonawalla was quoted as saying by the newspaper in an interview published on Friday. Poonawalla said last week that the Serum Institute would be able to raise its monthly output to ...
India's Serum Institute plans to start vaccine production outside India - The Times
India's Serum Institute plans to start vaccine production outside India - The Times
Source: Reuters
1/05/2021 10:46:54 AM
AstraZeneca forecast boosts shares as COVID shot sales hit $275 million AstraZeneca's COVID-19 vaccine delivered $275 million in first-quarter sales while shaving three cents per share from earnings, the drugmaker said on Friday as it posted better-than-expected results and forecast second half growth. This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of the vaccine, which it developed with Oxford University. It has said it will not make a profit from the shot during the pandemic. The vaccine re...
AstraZeneca forecast boosts shares as COVID shot sales hit $275 million
AstraZeneca forecast boosts shares as COVID shot sales hit $275 million
Source: Reuters
30/04/2021 4:11:59 PM
EU sues AstraZeneca over breach of COVID-19 vaccine supply contract BRUSSELS - The European Commission said on Monday it had launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines and for not having a "reliable" plan to ensure timely deliveries. AstraZeneca said in response that the legal action by the EU was without merit and pledged to defend itself strongly in court. Under the contract, the Anglo-Swedish company had committed to making its "best reasonable efforts" to deliver ...
EU sues AstraZeneca over breach of COVID-19 vaccine supply contract
EU sues AstraZeneca over breach of COVID-19 vaccine supply contract
Source: Reuters
27/04/2021 11:40:37 AM
U.S. to share up to 60 million AstraZeneca vaccine doses globally - White House WASHINGTON - The United States will start to share up to 60 million doses of AstraZeneca Plc's COVID-19 vaccine doses with other countries as they become available, White House senior COVID-19 adviser Andy Slavitt said on Monday. "U.S. to release 60 million AstraZeneca doses to other countries as they become available," he wrote on Twitter. The Associated Press earlier on Monday reported the doses would be shared in coming months following a federal safety review. The B...
U.S. to share up to 60 million AstraZeneca vaccine doses globally - White House
U.S. to share up to 60 million AstraZeneca vaccine doses globally - White House
Source: Reuters
27/04/2021 11:36:43 AM
India`s Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose NEW DELHI  - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95). "Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state ...
India`s Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose
India`s Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose
Source: Reuters
21/04/2021 12:51:34 PM
AstraZeneca woes grow as Australia, Philippines, African Union curb COVID shots Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the Africa Union dropped plans to buy the shot, dealing further blows to the company's hopes to deliver a vaccine for the world. The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concerns and supply problems since Phase III trial results were published in December, with Indonesia the latest country forced to...
AstraZeneca woes grow as Australia, Philippines, African Union curb COVID shots
AstraZeneca woes grow as Australia, Philippines, African Union curb COVID shots
Source: Reuters
9/04/2021 10:24:56 AM
Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it LONDON - Italy recommended on Wednesday that AstraZeneca's COVID-19 shot only be used on those over 60 and Britain that people under 30 should get an alternative, due to possible links between the vaccine and very rare cases of blood clots. More than a dozen countries have at one time suspended use of the vaccine, which has been given to tens of millions in Europe. But most have resumed, with some, including France, the Netherlands and Germany, recommending a minimum age. European U...
Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it
Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it
Source: Reuters
8/04/2021 10:44:45 AM
US halts AstraZeneca vax production at Baltimore plant A plant in the US which ruined 15 million potential doses of Johnson and Johnson's Covid-19 vaccine has been asked to stop producing doses for AstraZeneca, the media reported. The facility at Baltimore, Emergent Biosolutions, was earlier picked as a manufacturing partner for both AstraZeneca and Johnson and Johnson. In a statement on Saturday, Johnson and Johnson said it was "assuming full responsibility" regarding the manufacturing of drug substance for its Covid-19 vacci...
US halts AstraZeneca vax production at Baltimore plant
US halts AstraZeneca vax production at Baltimore plant
Source: IANS
4/04/2021 5:57:04 PM
Exclusive: Six-week sprint got Indian-made AstraZeneca vaccine approved in Canada TORONTO - Problems at AstraZeneca Plc's European production site in January kicked off a six-week push to get a version of its COVID-19 vaccine made at an Indian facility approved by Canada's drug regulator, according to the Canadian pharmaceutical company that filed the application. Last week, when Health Canada approved AstraZeneca's COVID-19 vaccine, it also cleared a version of the shot made by the Serum Institute of India (SII). SII filed the application with a Canadian pa...
Exclusive: Six-week sprint got Indian-made AstraZeneca vaccine approved in Canada
Exclusive: Six-week sprint got Indian-made AstraZeneca vaccine approved in Canada
Source: Reuters
2/03/2021 10:17:00 AM
AstraZeneca sold out of vaccine maker Moderna last year AstraZeneca sold a stake it held in rival COVID-19 vaccine maker Moderna over the course of last year, the Anglo-Swedish drugmaker's latest annual report shows. London-listed AstraZeneca did not specify how much it sold the stake for, but said that "a large proportion" of the $1.38 billion it recorded in equity portfolio sales last year came from the Moderna disposal. Moderna, whose coronavirus vaccine was cleared for U.S. emergency use in December, last week said it was e...
AstraZeneca sold out of vaccine maker Moderna last year
AstraZeneca sold out of vaccine maker Moderna last year
Source: Reuters
1/03/2021 5:37:25 PM
AstraZeneca says it will have no vaccine supply shortfall in second quarter, EU wary MILAN/BRUSSELS - AstraZeneca will deliver 180 million COVID-19 vaccines to Europe in the second quarter, including 20 million to Italy, the head of its Italian unit was quoted as saying on Thursday, but EU officials remained wary about supply. Reuters reported on Tuesday, citing an EU official directly involved in talks with the Anglo-Swedish drugmaker, that AstraZeneca expected to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second qua...
AstraZeneca says it will have no vaccine supply shortfall in second quarter, EU wary
AstraZeneca says it will have no vaccine supply shortfall in second quarter, EU wary
Source: Reuters
25/02/2021 4:14:18 PM
WHO approves AstraZeneca Covid-19 vaccine The World Health Organization (WHO) has listed two versions of the AstraZeneca/Oxford Covid-19 vaccine for emergency use including the one produced by the Serum Institute of India. The other version is produced by AstraZeneca-SKBio (Republic of Korea), the WHO said on Monday. The approval of these vaccines means giving the green light for them to be rolled out globally through COVAX. It also allows countries to expedite their own regulatory approval to import and administer Covid-19 ...
WHO approves AstraZeneca Covid-19 vaccine
WHO approves AstraZeneca Covid-19 vaccine
Source: IANS
16/02/2021 11:28:54 AM
With all eyes on COVID-19 vaccine, rest of AstraZeneca sees profits rising AstraZeneca on Thursday forecast 2021 revenue growth after the COVID-19 vaccine developer beat analysts' estimates for fourth-quarter product sales, as a wide range of therapies helped cushion the hit from the pandemic. The British drugmaker said it expects 2021 revenues to increase by a low teens percentage, with "faster growth" in core earnings to $4.75 to $5.00 per share. Quarterly product sales of $7.01 billion surpassed a company-compiled consensus of $6.81 billion. 2...
With all eyes on COVID-19 vaccine, rest of AstraZeneca sees profits rising
With all eyes on COVID-19 vaccine, rest of AstraZeneca sees profits rising
Source: Reuters
11/02/2021 12:54:37 PM
South Africa puts AstraZeneca vaccinations on hold over variant data JOHANNESBURG  - South Africa will put on hold use of AstraZeneca's COVID-19 shot in its vaccination programme, after data showed it gave minimal protection against mild-to-moderate infection caused by the country's dominant coronavirus variant. Health Minister Zweli Mkhize said on Sunday that the government would await advice from scientists on how best to proceed, after a trial showed the AstraZeneca vaccine did not significantly reduce the risk of mild or moderate COVID-19 f...
South Africa puts AstraZeneca vaccinations on hold over variant data
South Africa puts AstraZeneca vaccinations on hold over variant data
Source: Reuters
8/02/2021 9:47:48 AM
Exclusive: India to begin commercial vaccine exports with shipments to Brazil, Morocco NEW DELHI  - India's government has cleared commercial exports of COVID-19 vaccines, with the first consignments to be shipped to Brazil and Morocco on Friday, the Indian foreign secretary told Reuters. The shots developed by UK-based drugmaker AstraZeneca and Oxford University are being manufactured at the Serum Institute of India, the world's biggest producer of vaccines, which has received orders from countries across the world. The Indian government had held off exporti...
Exclusive: India to begin commercial vaccine exports with shipments to Brazil, Morocco
Exclusive: India to begin commercial vaccine exports with shipments to Brazil, Morocco
Source: Reuters
22/01/2021 9:27:59 AM
South Africa to pay $5.25 a dose for AstraZeneca vaccine from India`s SII JOHANNESBURG - South Africa will pay $5.25 per dose for 1.5 million shots of AstraZeneca's COVID-19 vaccine from the Serum Institute of India (SII), a senior health ministry official said on Thursday, more than some wealthier countries are paying. The price is higher than the $3 a dose that South Africa and other countries on the continent are due to pay for the same vaccines under an African Union (AU) arrangement, and the price European Union countries have agreed to pay. The...
South Africa to pay $5.25 a dose for AstraZeneca vaccine from India`s SII
South Africa to pay $5.25 a dose for AstraZeneca vaccine from India`s SII
Source: Reuters
21/01/2021 5:54:21 PM
India approves AstraZeneca's COVID-19 vaccine By Krishna N. Das NEW DELHI  - India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world's second most populous country. Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday the vaccine had been given the green light on Friday, confirming what sources close to the matter had told Reuters. It is the first COVID-19 vaccine to be approved for emergency use by...
India approves AstraZeneca's COVID-19 vaccine
India approves AstraZeneca's COVID-19 vaccine
Source: Reuters
2/01/2021 9:29:00 AM